Cardiovascular Complications During Delivery Admissions Associated With Assisted Reproductive Technology (from a National Inpatient Sample Analysis 2008 to 2019)

Published:October 23, 2022DOI:
      Women who conceive through assisted reproductive technology (ART) have a known increased risk of obstetric complications. However, whether ART is also associated with higher risk of developing cardiovascular complications during delivery admissions has not been well established. We used data from the National Inpatient Sample (2008 to 2019) and used the International Classification of Diseases codes to identify delivery hospitalizations and ART procedures. A total of 45,867,086 weighted delivery cases were identified, of which 0.24% were among women who conceived through ART (n = 108,542). Women with an ART history were older at the time of delivery (median 35 vs 28 years, p <0.01) and had a higher prevalence of hypertension, gestational diabetes, and dyslipidemia (all, p <0.01). After adjustment for age, race/ethnicity, co-morbidities, multiple gestation, insurance, and income, ART remained an independent predictor of peripartum cardiovascular complications, including pre-eclampsia/eclampsia (adjusted odds ratio [aOR] 1.48, 95% confidence interval [CI] 1.45 to 1.51), heart failure (aOR 1.94, 95% CI 1.10 to 3.40), and cardiac arrhythmias (aOR 1.39, 95% CI 1.30 to 1.48), compared with natural conception. Likewise, the risk of acute kidney injury (aOR 2.57, 95% CI 2.25 to 2.92), ischemic stroke (aOR 1.73, 95% CI 1.24 to 2.43), hemorrhagic stroke (aOR 1.63, 95% CI 1.27 to 2.11), pulmonary edema (aOR 2.29, 95% CI 2.02 to 2.61), and venous thromboembolism (aOR 1.92, 95% CI 1.63 to 2.25) were higher with ART. However, odds of developing peripartum cardiomyopathy or acute coronary syndrome were not associated with ART. Length of stay (3 vs 2 days, p <0.01) and cost of hospitalization ($5,903 vs $3,922, p <0.01) were higher for deliveries among women with a history of ART. In conclusion, women who conceived with ART had higher risk of pre-eclampsia, heart failure, arrhythmias, stroke, and other complications during their delivery hospitalizations. This may, in part, contribute to their increased resource utilization seen.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Jain M
        • Singh M.
        Assisted reproductive technology (ART) techniques.
        StatPearls. Treasure Island: StatPearls Publishing. 2022; (Available at:)
        • Ma RCW
        • Ng NYH
        • Cheung LP.
        Assisted reproduction technology and long-term cardiometabolic health in the offspring.
        PLoS Med. 2021; 18e1003724
        • Fauser BC.
        Towards the global coverage of a unified registry of IVF outcomes.
        Reprod Biomed Online. 2019; 38: 133-137
        • Nagata C
        • Yang L
        • Yamamoto-Hanada K
        • Mezawa H
        • Ayabe T
        • Ishizuka K
        • Konishi M
        • Ohya Y
        • Saito H
        • Sago H
        Japan Environment and Children's Study Group. Complications and adverse outcomes in pregnancy and childbirth among women who conceived by assisted reproductive technologies: a nationwide birth cohort study of Japan environment and children's study.
        BMC Pregnancy Childbirth. 2019; 19: 77
        • Wu P
        • Sharma GV
        • Mehta LS
        • Chew-Graham CA
        • Lundberg GP
        • Nerenberg KA
        • Graham MM
        • Chappell LC
        • Kadam UT
        • Jordan KP
        • Mamas MA.
        In-hospital complications in pregnancies conceived by assisted reproductive technology.
        J Am Heart Assoc. 2022; 11e022658
      1. AHRQ. Methods series. Available at: Accessed on December 29, 2021.

        • Zahid S
        • Khan MZ
        • Gowda S
        • Faza NN
        • Honigberg MC
        • Vaught AJ
        • Guan C
        • Minhas AS
        • Michos ED.
        Trends, predictors, and outcomes of cardiovascular complications associated With polycystic ovary syndrome during delivery hospitalizations: a National Inpatient Sample analysis (2002–2019).
        J Am Heart Assoc. 2022; 11e025839
        • Almasi-Hashiani A
        • Omani-Samani R
        • Mohammadi M
        • Amini P
        • Navid B
        • Alizadeh A
        • Khedmati Morasae E
        • Maroufizadeh S.
        Assisted reproductive technology and the risk of preeclampsia: an updated systematic review and meta-analysis.
        BMC Pregnancy Childbirth. 2019; 19: 149
        • World Health Organization
        WHO fact sheet on infertility.
        Glob Reprod Health. 2021; 6: e52
      2. CDC. Reproductive health: what is infertility? Available at: Accessed on August 16, 2022.

        • Mascarenhas MN
        • Flaxman SR
        • Boerma T
        • Vanderpoel S
        • Stevens GA.
        National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys.
        PLoS Med. 2012; 9e1001356
        • Boivin J
        • Bunting L
        • Collins JA
        • Nygren KG.
        International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care.
        Hum Reprod. 2007; 22: 1506-1512
      3. CDC. Assisted reproductive technology (ART): ART success rates. Available at: Accessed on August 16, 2022.

        • Sunderam S
        • Kissin DM
        • Zhang Y
        • Folger SG
        • Boulet SL
        • Warner L
        • Callaghan WM
        • Barfield WD.
        Assisted reproductive technology surveillance - United States, 2016.
        MMWR Surveill Summ. 2019; 68: 1-23
        • Wang AY
        • Safi N
        • Ali F
        • Lui K
        • Li Z
        • Umstad MP
        • Sullivan EA.
        Neonatal outcomes among twins following assisted reproductive technology: an Australian population-based retrospective cohort study.
        BMC Pregnancy Childbirth. 2018; 18: 320
        • Cromi A
        • Marconi N
        • Casarin J
        • Cominotti S
        • Pinelli C
        • Riccardi M
        • Ghezzi F.
        Maternal intra- and postpartum near-miss following assisted reproductive technology: a retrospective study.
        BJOG. 2018; 125: 1569-1578
        • Guan C
        • Zahid S
        • Minhas AS
        • Ouyang P
        • Vaught A
        • Baker VL
        • Michos ED.
        Polycystic ovary syndrome: a “risk-enhancing” factor for cardiovascular disease.
        Fertil Steril. 2022; 117: 924-935
        • Bosdou JK
        • Anagnostis P
        • Goulis DG
        • Lainas GT
        • Tarlatzis BC
        • Grimbizis GF
        • Kolibianakis EM.
        Risk of gestational diabetes mellitus in women achieving singleton pregnancy spontaneously or after ART: a systematic review and meta-analysis.
        Hum Reprod Update. 2020; 26: 514-544
        • Elkayam U
        • Gleicher N.
        Hemodynamics and cardiac function during normal pregnancy and the puerperium.
        Card Probl Preg Diagn Manag Matern Fetal Heart Dis. 1998; 1: 1
        • Ouzounian JG
        • Elkayam U.
        Physiologic changes during normal pregnancy and delivery.
        Cardiol Clin. 2012; 30: 317-329
        • Hall ME
        • George EM
        • Granger JP.
        The heart during pregnancy. Article in Spanish.
        Rev Esp Cardiol. 2011; 64s: 1045-1050
        • Sanghavi M
        • Rutherford JD.
        Cardiovascular physiology of pregnancy.
        Circulation. 2014; 130: 1003-1008
        • Walters WA
        • Lim YL.
        Cardiovascular dynamics in women receiving oral contraceptive therapy.
        Lancet. 1969; 2: 879-881
        • Ozkaya E
        • Kutlu T
        • Abide Yayla C
        • Kayatas Eser S
        • Sanverdi I
        • Devranoglu B
        Area under the curve of temporal estrogen and progesterone measurements during assisted reproductive technology: which hormone is the main determinant of cycle outcome?.
        J Obstet Gynaecol Res. 2018; 44: 263-269
        • Bloise E
        • Feuer SK
        • Rinaudo PF.
        Comparative intrauterine development and placental function of ART concepti: implications for human reproductive medicine and animal breeding.
        Hum Reprod Update. 2014; 20: 822-839
        • Nastri CO
        • Ferriani RA
        • Rocha IA
        • Martins WP.
        Ovarian hyperstimulation syndrome: pathophysiology and prevention.
        J Assist Reprod Genet. 2010; 27: 121-128
        • Crawford S
        • Boulet SL
        • Mneimneh AS
        • Perkins KM
        • Jamieson DJ
        • Zhang Y
        • Kissin DM.
        Costs of achieving live birth from assisted reproductive technology: a comparison of sequential single and double embryo transfer approaches.
        Fertil Steril. 2016; 105: 444-450
        • Connolly MP
        • Hoorens S
        • Chambers GM
        ESHRE Reproduction and Society Task Force. The costs and consequences of assisted reproductive technology: an economic perspective.
        Hum Reprod Update. 2010; 16: 603-613
        • Farley Ordovensky Staniec J
        • Webb NJ.
        Utilization of infertility services: how much does money matter?.
        Health Serv Res. 2007; 42: 971-989
        • Bae JM.
        Shared decision making: relevant concepts and facilitating strategies.
        Epidemiol Health. 2017; 39e2017048
        • Knight M
        • Bunch K
        • Tuffnell D
        • Shakespeare J
        • Kotnis R
        • Kenyon S
        • Kurinczuk JJ
        • ed. on behalf of MBRRACE-UK
        Saving lives, improving mothers’ care - lessons learned to inform maternity care from the UK and Ireland confidential enquiries into maternal deaths and morbidity 2015–17.
        National Perinatal Epidemiology Unit, University of Oxford, Oxford2019
        • Nelson-Piercy C.
        Is it time to screen for cardiometabolic risk factors prior to ART?.
        BJOG. 2020; 127: 940